Abstract
Benzopyrones have been shown to affect several functions of macrophages. We examined the effects of two benzopyrones, coumarin and warfarin, on the capacity of mouse macrophages to inhibit microorganisms and tumour target cells. Mice were treated with daily i.v. doses of either drug. Then the mice were challenged with lethal doses of Toxoplasma gondii or peritoneal macrophages from these mice were challenged in vitro with T. gondii or tumour target cells Survival of coumarin or warfarin-treated mice challenged with T. gondii was similar to that of control mice. Multiplication of T gondii and growth of tumour target cells were similar in preparations of macrophages from coumarin-treated, warfarin-treated, or control mice and were inhibited in preparations of activated macrophages from Corynebacterium parvum-treated mice that served as positive controls. Under our experimental conditions, benzopyrones did not activate mouse macrophages.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ADLERCREUTZ E., PETTERSSON T. Reticuloendothelial system and anticoagulant therapy. Studies with radioactive colloidal gold. Lancet. 1963 Mar 2;1(7279):470–471. doi: 10.1016/s0140-6736(63)92361-4. [DOI] [PubMed] [Google Scholar]
- Anderson S. E., Jr, Remington J. S. Effect of normal and activated human macrophages on Toxoplasma gondii. J Exp Med. 1974 May 1;139(5):1154–1174. doi: 10.1084/jem.139.5.1154. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bolton T., Casley-Smith J. R. An in vitro demonstration of proteolysis by macrophages and its increase with coumarin. Experientia. 1975 Mar 15;31(3):271–273. doi: 10.1007/BF01922534. [DOI] [PubMed] [Google Scholar]
- Dunn C. J., Koh M. S., Willoughby D. A., Giroud J. P. The value of multifactorial screening for anti-inflammatory activity as shown by coumarin. J Pathol. 1977 Aug;122(4):201–207. doi: 10.1002/path.1711220404. [DOI] [PubMed] [Google Scholar]
- Edwards R. L., Rickles F. R. Delayed hypersensitivity in man: effects of systemic anticoagulation. Science. 1978 May 5;200(4341):541–543. doi: 10.1126/science.644314. [DOI] [PubMed] [Google Scholar]
- Koh M. S., Willoughby D. A. A comparison of coumarin and levamisole on parameters of the inflammatory response. Agents Actions. 1979 Aug;9(3):284–288. doi: 10.1007/BF01966702. [DOI] [PubMed] [Google Scholar]
- Krahenbuhl J. L., Lambert L. H., Jr, Remington J. S. Effects of Corynebacterium parvum treatment and Toxoplasma gondii infection on macrophage-mediated cytostasis of tumour target cells. Immunology. 1976 Dec;31(6):837–846. [PMC free article] [PubMed] [Google Scholar]
- Krahenbuhl J. L., Remington J. S. The role of activated macrophages in specific and nonspecific cytostasis of tumor cells. J Immunol. 1974 Aug;113(2):507–516. [PubMed] [Google Scholar]
- Krahenbuhl J. L., Ruskin J., Remington J. S. The use of killed vaccines in immunization against an intracellular parasite: Toxoplasma gondii. J Immunol. 1972 Feb;108(2):425–431. [PubMed] [Google Scholar]
- McLeod R., Remington J. S. Influence of infection with Toxoplasma on macrophage function, and role of macrophages in resistance to Toxoplasma. Am J Trop Med Hyg. 1977 Nov;26(6 Pt 2):170–186. doi: 10.4269/ajtmh.1977.26.170. [DOI] [PubMed] [Google Scholar]
- McLeod R., Remington J. S. Studies on the specificity of killing of intracellular pathogens by macrophages. Cell Immunol. 1977 Nov;34(1):156–174. doi: 10.1016/0008-8749(77)90238-6. [DOI] [PubMed] [Google Scholar]
- Piller N. B. A morphological assessment of the stimulatory effect of coumarin on macrophages. Br J Exp Pathol. 1978 Feb;59(1):93–96. [PMC free article] [PubMed] [Google Scholar]
- Piller N. B. An integration of the modes of action of coumarin. An explanation of its effectiveness as a therapy for thermally injured tissue. Arzneimittelforschung. 1977;27(6):1135–1138. [PubMed] [Google Scholar]
- Piller N. B., Clodius L. The use of a tissue tonometer as a diagnostic aid in extremity lymphoedema: a determination of its conservative treatment with benzo-pyrones. Lymphology. 1976 Dec;9(4):127–132. [PubMed] [Google Scholar]
- Piller N. B. The enhancement of hyphema resolution following benzopyrone therapy in an experimental model. Exp Eye Res. 1978 Jun;26(6):725–727. doi: 10.1016/0014-4835(78)90107-0. [DOI] [PubMed] [Google Scholar]
- Piller N. B. The ineffectiveness of coumarin treatment on thermal oedema of macrophage-free rats. Br J Exp Pathol. 1976 Apr;57(2):170–178. [PMC free article] [PubMed] [Google Scholar]
- Wilson C. B., Tsai V., Remington J. S. Failure to trigger the oxidative metabolic burst by normal macrophages: possible mechanism for survival of intracellular pathogens. J Exp Med. 1980 Feb 1;151(2):328–346. doi: 10.1084/jem.151.2.328. [DOI] [PMC free article] [PubMed] [Google Scholar]